A5023186946- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis B Virus Studies
- Cell death mechanisms and regulation
- Cancer Mechanisms and Therapy
- RNA Interference and Gene Delivery
- Endoplasmic Reticulum Stress and Disease
- Pancreatic function and diabetes
- Multiple and Secondary Primary Cancers
- Liver physiology and pathology
- Organ Donation and Transplantation
- Animal Virus Infections Studies
- Alcohol Consumption and Health Effects
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
University of Padua
2024
Hôpital Paul-Brousse
2024
Assistance Publique – Hôpitaux de Paris
2024
University of Milan
2024
University of Palermo
2011
Bio-Nucleonics (United States)
2006
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
1986
Abstract Background The 2022 Barcelona Clinic Liver Cancer (BCLC) algorithm does not recommend liver resection (LR) in BCLC A patients with oligo-nodular (two or three nodules ≤3 cm) hepatocellular carcinoma (HCC). This sharply contrasts the therapeutic hierarchy concept, implying a precise treatment order exists within each stage. study aimed to compare outcomes of LR versus radiofrequency ablation (RFA) trans-arterial chemoembolization (TACE) patients. Methods meta-analysis adhering PRISMA...
Transarterial chemoembolisation (TACE) is first-line treatment in unresectable hepatocellular carcinoma (HCC) and rescue after failure of radical treatments early stage HCC. Prognostic tools for HCC using time-fixed Cox models may be unreliable patients treated with TACE because time-varying predictors interact.To explore time-dependent variables as survival receiving or second-line treatment.Eighty four consecutive (mean age 68; male gender 62%; Child-Pugh class: A n=73, B n=11; Barcelona...
Minimally invasive liver surgery (MILS) has been slowly introduced in the past two decades and today represents a major weapon fight against HCC, for several reasons. This narrative review conveys emerging concepts field. The rise metabolic-associated steatotic disease (MASLD)-related HCC means that patients with significant cardiovascular risk will benefit more profoundly from MILS. advent of efficacious therapy is leading to conversion non-resectable resectable cases, therefore be able...
BackgroundInternational consensus has recently introduced a new definition of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). We sought to analyse epidemiological trends, prognostic features, and transplant survival benefits MASLD non-MASLD patients waiting for liver transplantation (LT) in Italy.Materials methodsUtilising the Italian Transplant Registry database, we analysed data from adult listed primary LT due end-stage chronic disease between January 2012 December 2022....
Background: Despite the ongoing trend of increasing donor ages in liver transplantation (LT) setting, a notable gap persists availability comprehensive guidelines for utilization organs from elderly donors. This study aimed to evaluate viability livers grafts donors aged ≥85 years and report post-LT outcomes compared with those “ideal” under 40 old. Methods: Conducted retrospectively at single center 2005 2023, this LTs y/o ≤40 y/o, propensity score matching recipient’s gender, age, BMI,...
Introduction: Laparoscopic liver resection (LLR) is worldwide accepted as a safe and curative approach for hepatocellular carcinoma (HCC), both in the very-early early stage. Nowadays, according to BCLC 2022 update, Transarterial Chemoembolization (TACE) "Extend criteria" Liver Transplant are only treatment options Intermediate stage HCC (BCLC-B). In recent years, several retrospective studies have been reported literature on possibility of offering treatments BCLC-B patients. Resection used...
On the basis of 211 hepatic resections and reresections, a study was made to evaluate possibility compiling checklist for primary liver tumours according TNM classification. This would aid surgeon in planning therapy provide useful guide prognosis late results.